Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma

Cancer

Volumn 119, Issue 10, 2013, Pages 1885-1891

  Xie, Hui ^a,b   Wu, Xifeng ^a   Wang, Shui ^c   Chang, David ^a   Pollock, Raphael E ^a   Lev, Dina ^a   Gu, Jian ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cancer risk; peripheral blood leukocytes; soft tissue sarcoma; telomere length

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HISPANIC; HISTOLOGY; HUMAN; LEIOMYOSARCOMA; LEUKOCYTE; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PATIENT PARTICIPATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEX; SOFT TISSUE SARCOMA; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

ADULT; AGED; CASE-CONTROL STUDIES; CHROMOSOMAL INSTABILITY; FEMALE; HUMANS; INCIDENCE; LEIOMYOSARCOMA; LEUKOCYTES; LIPOSARCOMA; MALE; MIDDLE AGED; ODDS RATIO; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION; SARCOMA; TELOMERE; UNITED STATES;

EID: 84877583425     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27984     Document Type: Article

References (42)

1. Blackburn EH, Greider CW, Szostak JW,. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med. 2006; 12: 1133-1138.
2. Palm W, de Lange T,. How shelterin protects mammalian telomeres. Annu Rev Genet. 2008; 42: 301-334.
3. Gasser SM,. A sense of the end. Science. 2000; 288: 1377-1379.
4. Shore D,. Telomeric chromatin: replicating and wrapping up chromosome ends. Curr Opin Genet Dev. 2001; 11: 189-198.
5. Klapper W, Parwaresch R, Krupp G,. Telomere biology in human aging and aging syndromes. Mech Ageing Dev. 2001; 122: 695-712.
6. Calado RT, Young NS,. Telomere diseases. N Engl J Med. 2009; 361: 2353-2365.
7. Mathon NF, Lloyd AC,. Cell senescence and cancer. Nat Rev Cancer. 2001; 1: 203-213.
8. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366: 662-664.
9. McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I,. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007; 16: 815-819.
10. Morla M, Bsquets X, Pons J, Sauleda J, MacNee W, Agusti AG,. Telomere shortening in smokers with and without COPD. Eur Respir J. 2006; 27: 525-528.
11. von Zglinicki T,. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002; 27: 339-344.
12. Serra V, von Zglinicki T, Lorenz M, Saretzki G,. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem. 2003; 278: 6824-6830.
13. Fernandez-Egea E, Bernardo M, Heaphy CM, et al. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull. 2009; 35: 437-442.
14. Epel ES, Lin J, Wilhelm FH, et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006; 31: 277-287.
15. Bekaert S, De Meyer T, Rietzschel ER, et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell. 2007; 6: 639-647.
16. Kim S, Parks CG, DeRoo LA, et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev. 2009; 18: 816-820.
17. Cherkas LF, Aviv A, Valdes AM, et al. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell. 2006; 5: 361-365.
18. Lansdorp PM,. Stress, social rank and leukocyte telomere length. Aging Cell. 2006; 5: 583-584.
19. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003; 95: 1211-1218.
20. Ma H, Zhou Z, Wei S, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis [serial online]. PLoS One. 2011; 6: e20466.
21. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA,. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1238-1250.
22. Hou L, Zhang X, Gawron AJ, Liu J,. Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett. 2012; 319: 130-135.
23. Mirabello L, Richards EG, Duong LM, et al. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet. 2011; 2: 19-29.
24. Clark MA, Fisher C, Judson I, Thomas JM,. Soft-tissue sarcomas in adults. N Engl J Med. 2005; 353: 701-711.
25. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
26. Schoffski P, Ray-Coquard IL, Cioffi A, et al. Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in 4 independent histological subtypes. Lancet Oncol. 2011; 12: 1045-1052.
27. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001; 91: 1914-1926.
28. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2001. Available at: http://seer.cancer.gov/csr/1975-2009-pops09/ [based on November 2011 SEER data submission, posted to the SEER web site, 2012]. Accessed December 1, 2012.
29. Abraham JA, Baldini EH, Butrynski JE,. Management of adult soft-tissue sarcoma of the extremities and trunk. Expert Rev Anticancer Ther. 2010; 10: 233-248.
30. Cawthon RM,. Telomere measurement by quantitative PCR [serial online]. Nucleic Acids Res. 2002; 30: e47.
31. Xing J, Ajani JA, Chen M, et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila). 2009; 2: 459-465.
32. Gu J, Chen M, Shete S, et al. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res (Phila). 2011; 4: 514-521.
33. Kim S, Sandler DP, Carswell G, et al. Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study. Cancer Causes Control. 2011; 22: 1061-1066.
34. Pooley KA, Sandhu MS, Tyrer J, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010; 70: 3170-3176.
35. Zee RY, Castonguay AJ, Barton NS, Buring JE,. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2280-2282.
36. De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ,. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1152-1156.
37. Mirabello L, Huang WY, Wong JY, et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell. 2009; 8: 405-413.
38. Yan P, Benhattar J, Coindre JM, Guillou L,. Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas. Int J Cancer. 2002; 98: 851-856.
39. Sinha S, Peach AH,. Diagnosis and management of soft tissue sarcoma [serial online]. BMJ. 2010; 341: c7170.
40. DePinho RA,. The age of cancer. Nature. 2000; 408: 248-254.
41. Hackett JA, Greider CW,. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene. 2002; 21: 619-626.
42. Lan Q, Cawthon R, Shen M, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 2009; 15: 7429-7433.